Acromegaly

7 trials 1 recruiting MedDRA PT
7 Registered trials
1 Recruiting
5 Unique sponsors
4 Unique IMPs
7 Commercial trials
Drug classes (ATC)
— ATC code not specified 6
H Endocrinology (ATC H) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 4 substances
Phase III: 4 Phase II: 2 Phase I: 1

Filter these 7 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 7 trials

Phase III

4 trials
  • Camurus AB Commercial
    OCTREOTIDE HYDROCHLORIDE
    2024-510667-33-00 5 countries 2021 n=35 Orphan
    Ended
  • Crinetics Pharmaceuticals Inc. Commercial
    PALTUSOTINE
    2024-511924-15-00 7 countries 2022 n=61
    Ended
  • Crinetics Pharmaceuticals Inc. Commercial
    PALTUSOTINE
    2024-511925-71-00 6 countries 2021 n=20
    Ended
  • Debiopharm International S.A. Commercial
    OCTREOTIDE
    2024-516616-24-00 16 countries 2025 n=100
    Recruiting

Phase II

2 trials
  • Alexion Pharmaceuticals Inc. Commercial
    ALXN2420
    2025-521243-20-00 7 countries 2025 n=32
    Halted
  • Crinetics Pharmaceuticals Inc. Commercial
    PALTUSOTINE
    2024-511921-75-00 3 countries 2020 n=10
    Ended

Phase I

1 trial
  • Amolyt Pharma Commercial
    IMP not specified
    2023-503734-47-00 1 country 2023 n=101
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Crinetics Pharmaceuticals Inc. Commercial 3 Phase II, Phase III 0
Amolyt Pharma Commercial 1 Phase I 0
Alexion Pharmaceuticals Inc. Commercial 1 Phase II 0
Camurus AB Commercial 1 Phase III 0
Debiopharm International S.A. Commercial 1 Phase III 1
New trials by year
2020
1
2021
2
2022
1
2023
1
2025
2
← All indication landscapes